Uploaded June 2026 | Updated September 2026, 2 weeks ago
This webinar provides an overview of the considerations for use of GLP-1 receptor agonist medications for people with Type 2 diabetes. Learn about the current guidelines for pharmacological management of Type 2 diabetes, the benefits of using GLP-1 medications such as their cardiovascular and kidney protective effects, and ways to overcome common prescribing barriers. To learn more about the American Heart Association's Target: Type 2 Diabetes program, visit heart.org/TargetType2Diabetes.
This webinar provides an overview of the considerations for use of GLP-1 receptor agonist medications for people with Type 2 diabetes. Learn about the current guidelines for pharmacological management of Type 2 diabetes, the benefits of using GLP-1 medications such as their cardiovascular and kidney protective effects, and ways to overcome common prescribing barriers. To learn more about the American Heart Association's Target: Type 2 Diabetes program, visit heart.org/TargetType2Diabetes.










